Showing results (391-400 of 811) with videos related to

Sort By:
Pageof 82
Liver International : Official Journal of the International Association for the Study of the Liver|August 18, 2019
The value of different CT-based methods for diagnosing low muscle mass and predicting mortality in patients with cirrhosisRafael Paternostro, Katharina Lampichler, Constanze Bardach, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|January 21, 2006
Upregulation of a basolateral FXR-dependent bile acid efflux transporter OSTalpha-OSTbeta in cholestasis in humans and rodentsJames L Boyer, Michael Trauner, Albert Mennone, et al.
JAMA|September 29, 2011
Sex-specific prevalence of adenomas, advanced adenomas, and colorectal cancer in individuals undergoing screening colonoscopyMonika Ferlitsch, Karoline Reinhart, Sibylle Pramhas, et al.
Nature Reviews. Disease Primers|March 14, 2025
Primary sclerosing cholangitisMichael P Manns, Annika Bergquist, Tom H Karlsen, et al.
The American Journal of Gastroenterology|July 15, 2024
Impact of Bowel Preparation Quality on Colonoscopy Findings and Colorectal Cancer Deaths in a Nation-Wide Colorectal Cancer Screening ProgramJasmin Zessner-Spitzenberg, Elisabeth Waldmann, Lisa-Maria Rockenbauer, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|September 13, 2023
Detection of high-risk polyps at screening colonoscopy indicates risk for liver and biliary cancer deathJasmin Zessner-Spitzenberg, Arnulf Ferlitsch, Elisabeth Waldmann, et al.
JAMA Network Open|December 6, 2023
Colorectal Cancer and Precursor Lesion Prevalence in Adults Younger Than 50 Years Without SymptomsDaniela Penz, Elisabeth Waldmann, Monika Hackl, et al.
JHEP Reports : Innovation in Hepatology|October 16, 2023
Non-steroidal FXR agonist cilofexor improves cholestatic liver injury in the Mdr2-/- mouse model of sclerosing cholangitisClaudia D Fuchs, Natalie Sroda, Hubert Scharnagl, et al.
Alimentary Pharmacology & Therapeutics|July 31, 2023
Diabetes impairs the haemodynamic response to non-selective betablockers in compensated cirrhosis and predisposes to hepatic decompensationRafael Paternostro, Mathias Jachs, Lukas Hartl, et al.
Hepatology (Baltimore, Md.)|April 26, 2012
von Willebrand factor as new noninvasive predictor of portal hypertension, decompensation and mortality in patients with liver cirrhosisMonika Ferlitsch, Thomas Reiberger, Matthias Hoke, et al.
Pageof 82